The impact of sickle cell disease and its treatment on ovarian reserve in reproductive‐aged Black women
- 6 June 2024
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 205 (2) , 674-685
Abstract
Summary: We compared serum anti‐Mullerian hormone (AMH) levels in women with sickle cell disease (SCD) (n = 152) to those of Black comparison women (n = 128) between the ages of 20 and 45 years and evaluated the impact of hydroxyurea (HU) and iron overload on ovarian reserve in those with SCD. SCD treatment was abstracted from medical records. Linear regression models were fit to examine the relationship between log(AMH) and SCD, adjusting for age. The analysis was repeated to account for HU use (current, previous, never) and iron overload (ferritin ≥1000 ng/mL vs. <1000 ng/mL). AMH estimates among women with SCD were lower than those among comparison women (2.23, 95% confidence interval [CI] 1.80–2.76 vs. 4.12, 95% CI 3.11–5.45, respectively). Women with SCD who were currently using HU had 63% lower (95% CI 43–76) AMH values than comparison women; those with SCD with prior or no HU use also had lower AMH estimates than comparison women, but the difference was less pronounced. There were no differences in predicted AMH values among women with SCD for those with and without iron overload. Women with SCD and low AMH may have a shorter reproductive window and may benefit from referral to a reproductive specialist.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD066059, R21 HD103030)
- Division of Loan Repayment (#1L50HD110031‐01)
This publication has 44 references indexed in Scilit:
- Infertility and treatment‐seeking practices among females and males with sickle cell disease in the Sickle Cell Disease Implementation Consortium registryPediatric Blood & Cancer, 2023
- Iron overload disordersHepatology Communications, 2022
- Patient‐focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell diseaseAmerican Journal of Hematology, 2021
- The role of anti-Müllerian hormone (AMH) in ovarian disease and infertilityJournal of Assisted Reproduction and Genetics, 2019
- Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell DiseaseJAMA Network Open, 2019
- Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive AgeJAMA, 2017
- The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVFJournal of Endocrinological Investigation, 2016
- Evolution of sickle cell disease from a life‐threatening disease of children to a chronic disease of adults: The last 40 yearsAmerican Journal of Hematology, 2015
- Sickle cell disease related mortality in the United States (1999-2009)Pediatric Blood & Cancer, 2013
- Population Estimates of Sickle Cell Disease in the U.S.American Journal of Preventive Medicine, 2010